Correlation Between Emergent Biosolutions and MIRA Pharmaceuticals,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and MIRA Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and MIRA Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and MIRA Pharmaceuticals, Common, you can compare the effects of market volatilities on Emergent Biosolutions and MIRA Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of MIRA Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and MIRA Pharmaceuticals,.

Diversification Opportunities for Emergent Biosolutions and MIRA Pharmaceuticals,

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Emergent and MIRA is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and MIRA Pharmaceuticals, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MIRA Pharmaceuticals, and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with MIRA Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MIRA Pharmaceuticals, has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and MIRA Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and MIRA Pharmaceuticals,

Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 1.11 times more return on investment than MIRA Pharmaceuticals,. However, Emergent Biosolutions is 1.11 times more volatile than MIRA Pharmaceuticals, Common. It trades about -0.03 of its potential returns per unit of risk. MIRA Pharmaceuticals, Common is currently generating about -0.26 per unit of risk. If you would invest  927.00  in Emergent Biosolutions on September 15, 2024 and sell it today you would lose (58.00) from holding Emergent Biosolutions or give up 6.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Emergent Biosolutions  vs.  MIRA Pharmaceuticals, Common

 Performance 
       Timeline  
Emergent Biosolutions 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent fundamental drivers, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.
MIRA Pharmaceuticals, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MIRA Pharmaceuticals, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, MIRA Pharmaceuticals, is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Emergent Biosolutions and MIRA Pharmaceuticals, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Emergent Biosolutions and MIRA Pharmaceuticals,

The main advantage of trading using opposite Emergent Biosolutions and MIRA Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, MIRA Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MIRA Pharmaceuticals, will offset losses from the drop in MIRA Pharmaceuticals,'s long position.
The idea behind Emergent Biosolutions and MIRA Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Directory
Find actively traded commodities issued by global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments